Wuwei Yang
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Sarcoma Diagnosis and Treatment 3
- Lung Cancer Diagnosis and Treatment 3
- Medical Imaging and Pathology Studies 2
- Oncology 6
- Cancer Diagnosis and Treatment 2
- Co-authors
- Li Li (1 shared paper)Donggang Xu (1 shared paper)Jing Lin (2 shared papers)Kaiwen Hu (3 shared papers)Peng Huang (2 shared papers)Hui Xie (2 shared papers)Xiujuan Chang (2 shared papers)Yongping Yang (2 shared papers)
- Journals
- The Oncologist (1 paper)Cancer Biology & Therapy (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wuwei Yang
21 papers receiving 652 citations
Peers
Comparison fields: 5 of 84
- Hepatology 205
- Biomaterials 104
- Pharmaceutical Science 25
- Oncology 99
- Biomedical Engineering 155
Countries citing papers authored by Wuwei Yang
This map shows the geographic impact of Wuwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuwei Yang more than expected).
Fields of papers citing papers by Wuwei Yang
This network shows the impact of papers produced by Wuwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuwei Yang. The network helps show where Wuwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 197 | |
| 2 | 2018 | 123 | |
| 3 | 2014 | 67 | |
| 4 | 2017 | 50 | |
| 5 | 2017 | 43 | |
| 6 | Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. | 2005 | 26 |
| 7 | 2018 | 24 | |
| 8 | 2014 | 22 | |
| 9 | 2019 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2018 | 12 | |
| 12 | 2020 | 11 | |
| 13 | [Study on the efficacy and safety of ultrasound ablation in treatment of uterine fibroids]. | 2010 | 11 |
| 14 | 2022 | 10 | |
| 15 | 2018 | 10 | |
| 16 | 2012 | 8 | |
| 17 | [Analysis of complications of high intensity focused ultrasound in treatment of uterine leiomyoma]. | 2010 | 5 |
| 18 | 2017 | 4 | |
| 19 | 2018 | 3 | |
| 20 | 2019 | 2 |
About Wuwei Yang
Wuwei Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Biomedical Engineering and Biomaterials, having authored 22 papers that have together received 664 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Sarcoma Diagnosis and Treatment (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Medical Imaging and Pathology Studies (2 papers), Graphene and Nanomaterials Applications (2 papers), Uterine Myomas and Treatments (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (205 citations), Biomaterials (104 citations), Pharmaceutical Science (25 citations), Oncology (99 citations) and Biomedical Engineering (155 citations). Wuwei Yang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Li Li, Donggang Xu, Jing Lin, Kaiwen Hu, Peng Huang, Hui Xie, Xiujuan Chang, Yongping Yang, Linjing An and Ke‐Qin Hu. Their work appears in journals such as The Oncologist, Cancer Biology & Therapy, JNCI Journal of the National Cancer Institute, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.